billion Medicare biz forecast error Walgreens

billion Medicare biz forecast error Walgreens -

In addition, the Wall Street Journal examines the collapse of the vascular IPO Biogenics.

The Wall Street Journal: Walgreen Shakeup Followed Bad Projection
One billion dollars forecast error in the health insurance business related Walgreen Co. has cost the jobs of two executives and alarmed the great investors. At a meeting of the board in April, Chief Financial Officer Wade Miquelon provides $ 8.5 billion for the fiscal year 2016 the pharmacy benefit unit, based in part on Sale of drugs by Medicare (Siconolfi, 8 / 19)

the Wall Street Journal broke Ruined .: commitment Biogenics vascular IPO
events that led to the collapse of the IPO has not been previously reported. The very unusual event - many traders and investors struggle to remember another IPO being canceled so - is a major setback for a company that is looking for money to pay for clinical trials to complete its work about treatments for cancer and other diseases. For executives, it has also raised questions about the role of insurers in a bid (Demos, 8/19).

---

This article has been reprinted kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a professional health policy research non-partisan organization affiliated with Kaiser Permanente.